{"title":"Understanding the Relationship between Knowledge Management and Pharmaceutical Innovation Empirical Study","authors":"Elham Elshafie Mohamed","doi":"10.58396/bcpr020102","DOIUrl":null,"url":null,"abstract":"Purpose: This research aims to understand the role of knowledge management (KM) approaches in pharmaceutical innovation; a comprehensive investigation using a multidisciplinary approach toward the integrative concepts of KM has been carried out. Consequently, this research recognizes to what extent pharmaceutical organizations in the UK successfully apply the KM. Design/methodology/approach The questionnaire survey method was deployed to collect data from pharmaceutical organizations in the UK. Many statistical procedures have been undertaken—exploratory factor analysis (EFA). One sample - T-test analysis and AMOS. Multiple regression analysis, path analysis, and SPSS were used. Findings – Two Proposed models were examined. The empirical assessment's overall result was significant, reflecting the appropriateness of the proposed model. All the constructs revealed a high level of internal consistency reliability. A good model fit was found for the measurement model using several fit indicators such as GFI, AGFI, and RMR. The findings also reveal that Knowledge management has a signifificant and positive impact on all innovation dimensions. It is also found that KM processes have a mediate effect on the relationship between knowledge management enablers and pharmaceutical innovation, Originality/value – This study is probably one of the critical studies that propose and examine the fit model as an integrative perspective for implementing KM in pharmaceutical organizations in the UK. It gives a guide for organizations to accomplish innovation through KM.","PeriodicalId":359310,"journal":{"name":"Basic and Clinical Pharmacy Research","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic and Clinical Pharmacy Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58396/bcpr020102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This research aims to understand the role of knowledge management (KM) approaches in pharmaceutical innovation; a comprehensive investigation using a multidisciplinary approach toward the integrative concepts of KM has been carried out. Consequently, this research recognizes to what extent pharmaceutical organizations in the UK successfully apply the KM. Design/methodology/approach The questionnaire survey method was deployed to collect data from pharmaceutical organizations in the UK. Many statistical procedures have been undertaken—exploratory factor analysis (EFA). One sample - T-test analysis and AMOS. Multiple regression analysis, path analysis, and SPSS were used. Findings – Two Proposed models were examined. The empirical assessment's overall result was significant, reflecting the appropriateness of the proposed model. All the constructs revealed a high level of internal consistency reliability. A good model fit was found for the measurement model using several fit indicators such as GFI, AGFI, and RMR. The findings also reveal that Knowledge management has a signifificant and positive impact on all innovation dimensions. It is also found that KM processes have a mediate effect on the relationship between knowledge management enablers and pharmaceutical innovation, Originality/value – This study is probably one of the critical studies that propose and examine the fit model as an integrative perspective for implementing KM in pharmaceutical organizations in the UK. It gives a guide for organizations to accomplish innovation through KM.